ArticleCancer cell international2022

Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma.

Jiaojiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.